Related Experiment Video
Updated: Jun 22, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women
Krista A Varady1, Lisa Tussing, Surabhi Bhutani
1Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA. varady@uic.edu
Achieving a 5% weight loss in severely obese women significantly improves adipokine profiles and reduces fat cell size. Greater weight loss (5%–10%) further enhances these beneficial changes in adipocyte physiology.
Area of Science:
- Obesity research
- Metabolic disease
- Adipose tissue biology
Background:
- Adipose tissue plays a critical role in disease risk.
- Weight loss in obesity improves adipocyte physiology.
- The minimum weight loss threshold for these improvements is not well-defined.
Purpose of the Study:
- To determine the minimum weight loss needed to improve adipokine profiles and reduce fat cell size in severely obese women.
Main Methods:
- Thirteen severely obese women (BMI 50±3 kg/m²) underwent a 3-week low-calorie diet.
- Participants were categorized into <5% or 5%–10% body weight loss groups.
- Adipokine levels, fat cell size, insulin, and glucose were measured.
Main Results:
- A weight loss of 5%–10% increased adiponectin by 20% and decreased leptin and resistin by 37% and 27%, respectively.
- Visceral and subcutaneous fat cell size decreased by 41% and 37% in the 5%–10% weight loss group.
- Smaller visceral adipocyte size correlated with lower insulin and glucose levels.
Conclusions:
- A minimum weight loss of 5% is necessary to improve adipokine profiles and reduce fat cell size in severely obese women.
- These physiological changes may contribute to reduced metabolic disease risk.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

